Funds and ETFs Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 12:54:28 2024-05-13 pm EDT 5-day change 1st Jan Change
211.1 USD +1.63% Intraday chart for Laboratory Corporation of America Holdings +4.75% -7.35%

ETFs positioned on Laboratory Corporation of America Holdings

Name Weight AuM 1st Jan change Investor Rating
0.03% 1,166 M€ +0.26%
0.03% 607 M€ +0.05%
0.03% 391 M€ +8.67% -
0.03% 234 M€ +3.18% -
0.03% 34 M€ +8.24% -
0.03% 284 M€ -.--%
0.02% 45 M€ 0.00% -
0.02% 306 M€ +5.68% -
0.02% 39 M€ +5.63% -
0.02% 1,174 M€ +23.54%
0.02% 273 M€ -.--%
0.02% 655 M€ -.--% -
0.02% 1 M€ -.--%
0.02% 17 M€ +4.33% -
0.02% 17 M€ +2.80% -
0.02% 105 M€ +3.54% -
0.01% 7 M€ +0.11% -
0.01% 34 M€ +3.77% -
0.01% 32 M€ +0.82% -
0.01% 205 M€ -.--%
0.01% 6 M€ +3.89%
0.01% 8 M€ +0.50% -
0.01% 2 M€ +3.16% -
0.01% 54 M€ +0.54% -
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
207.7 USD
Average target price
239.6 USD
Spread / Average Target
+15.38%
Consensus
  1. Stock Market
  2. Equities
  3. LH Stock
  4. Funds and ETFs Laboratory Corporation of America Holdings
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW